2019 -now Co-Founder, President, and Chief Business Officer @
2022 -now Angel Investor @
2021 -now Angel Investor @
2021 -now Angel Investor @
2020 -now Angel Investor @
2019 -now Angel Investor @
2019 -now Angel Investor @
2017 -now Chair, Board Of Directors @
2018 -now Board Member @
2020 -2023 Executive In Residence @
2018 -2020 Director @
2016 -2018 Principal, Life Sciences @
2021 -2022 Angel Investor @
2019 -2022 Board Member @
2018 -2022 Board Observer @
2021 -2021 Angel Investor @
2020 -2021 Angel Investor @
2018 -2021 Board Member @
2017 -2019 Board Observer @ Myoneuxs Therapeutics
2016 -2017 Postdoctoral Research Fellow @
2015 -2017 Physician Panelist @
2013 -2013 MD Intern @
2012 -2012 Visiting Research Scholar @
2009 -2010 Research Assistant @
2008 -2010 Research Assistant @
2004 -2007 Engineering Aide @
Samuel Lee Education
Stanford University Graduate School of Business
Business Administration and Entrepreneurship
The Johns Hopkins University
Masters (Public Health & Health Care Management)
University of Cincinnati
Doctor of Medicine (M.D.)
Miami University
Bachelor of Arts (B.A.) (Biochemistry)
Samuel Lee Summary
Samuel Lee, based in United States, is currently a Co-Founder, President, and Chief Business Officer at Eikonoklastes Therapeutics, Inc.. Samuel Lee brings experience from previous roles at American Gene Technologies® International Inc., Copy.ai, Vincere Biosciences and Swift Solar. Samuel Lee holds a Business Administration and Entrepreneurship @ Stanford University Graduate School of Business. Samuel Lee has 3 emails and 4 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.